ConductScience.org, home

Paper2328313

Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging.

Gorin NC and 9 others. Blood, 1990. Cited by 339 papers, by iCite.

Cite this record

ConductScience Library. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Papers, record 2328313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2328313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging.
PubMed
Journal
Blood
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
339
iCite
Relative citation ratio, by iCite
11.1
iCite
Revised in PubMed
2021-02-16
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gorin NCN C
2Aegerter PP
3Auvert BB
4Meloni GG
5Goldstone AHA H
6Burnett AA
7Carella AA
8Korbling MM
9Herve PP
10Maraninchi DD

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow TransplantationMajor topic
Leukemia, Myeloid, AcuteMajor topic
Transplantation, AutologousMajor topic
Adolescent
Adult
Aged
Antineoplastic Agents
Bone Marrow
Child
Child, Preschool
Cyclophosphamide
Europe
Female
Humans
Infant
Male
Middle Aged
Recurrence
Remission, Spontaneous

Source PubMed

Download CSV of topics

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 339 citations.

PMIDTitleJournalYearIn PapersSource
36639572Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro.Bone Marrow Transplant2023https://conductscience.org/library/papers/36639572PubMed
34820613History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia.Clin Hematol Int2021https://conductscience.org/library/papers/34820613PubMed
30235847Autologous Transplantation for Older Adults with AML.Cancers (Basel)2018https://conductscience.org/library/papers/30235847PubMed
25637051T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.Haematologica2015https://conductscience.org/library/papers/25637051PubMed
24816236
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica2014https://conductscience.org/library/papers/24816236PubMed
23505606Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia.Mediterr J Hematol Infect Dis2013https://conductscience.org/library/papers/23505606PubMed
19001282
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
Haematologica2009https://conductscience.org/library/papers/19001282PubMed
17589537Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant.Bone Marrow Transplant2007https://conductscience.org/library/papers/17589537PubMed
17563741Autologous bone marrow transplantation for children with AML in first remission.Bone Marrow Transplant2007https://conductscience.org/library/papers/17563741PubMed
17450184Viral purging of haematological autografts: should we sneeze on the graft?Bone Marrow Transplant2007https://conductscience.org/library/papers/17450184PubMed
15908982Elevated levels of WT1 transcripts in bone marrow harvests are associated with a high relapse risk in patients autografted for acute myeloid leukaemia.Bone Marrow Transplant2005https://conductscience.org/library/papers/15908982PubMed
15094749Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cells.Bone Marrow Transplant2004https://conductscience.org/library/papers/15094749PubMed
12732879Autologous stem cell transplantation for acute myeloid leukemia.Bone Marrow Transplant2003https://conductscience.org/library/papers/12732879PubMed
12105772Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia.Bone Marrow Transplant2002https://conductscience.org/library/papers/12105772PubMed
11896428Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging.Bone Marrow Transplant2002https://conductscience.org/library/papers/11896428PubMed
11368436Transplantation of IL-2-mobilized autologous peripheral blood progenitor cells for adults with acute myelogenous leukemia in first remission.Leukemia2001https://conductscience.org/library/papers/11368436PubMed
10865965
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Leukemia2000https://conductscience.org/library/papers/10865965PubMed
10849522Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis.Bone Marrow Transplant2000https://conductscience.org/library/papers/10849522PubMed
10808203Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.Bone Marrow Transplant2000https://conductscience.org/library/papers/10808203PubMed
10808202Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.Bone Marrow Transplant2000https://conductscience.org/library/papers/10808202PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2328313

GET https://conductscience.org/api/papers/v1/2328313/cited_by?page=2